Bartram, C R; Schrauder, A; Köhler, R; Schrappe, M Acute Lymphoblastic Leukemia in Children: Treatment Planning via Minimal Residual Disease Assessment Dtsch Arztebl Int 2012; 109(40): 652-8; DOI: 10.3238/arztebl.2012.0652
Bartram, C R; Schrauder, A; Köhler, R; Schrappe, M Acute Lymphoblastic Leukemia in Children: Treatment Planning via Minimal Residual Disease Assessment Dtsch Arztebl Int 2012; 109(40): 652-8; DOI: 10.3238/arztebl.2012.0652
Bartram, C R; Schrauder, A; Köhler, R; Schrappe, M Acute Lymphoblastic Leukemia in Children: Treatment Planning via Minimal Residual Disease Assessment Dtsch Arztebl Int 2012; 109(40): 652-8; DOI: 10.3238/arztebl.2012.0652
Bartram, C R; Schrauder, A; Köhler, R; Schrappe, M Acute Lymphoblastic Leukemia in Children: Treatment Planning via Minimal Residual Disease Assessment Dtsch Arztebl Int 2012; 109(40): 652-8; DOI: 10.3238/arztebl.2012.0652
Bartram, C R; Schrauder, A; Köhler, R; Schrappe, M Acute Lymphoblastic Leukemia in Children: Treatment Planning via Minimal Residual Disease Assessment Dtsch Arztebl Int 2012; 109(40): 652-8; DOI: 10.3238/arztebl.2012.0652
Bartram, C R; Schrauder, A; Köhler, R; Schrappe, M Acute Lymphoblastic Leukemia in Children: Treatment Planning via Minimal Residual Disease Assessment Dtsch Arztebl Int 2012; 109(40): 652-8; DOI: 10.3238/arztebl.2012.0652
Bartram, C R; Schrauder, A; Köhler, R; Schrappe, M Acute Lymphoblastic Leukemia in Children: Treatment Planning via Minimal Residual Disease Assessment Dtsch Arztebl Int 2012; 109(40): 652-8; DOI: 10.3238/arztebl.2012.0652
Bartram, C R; Schrauder, A; Köhler, R; Schrappe, M Acute Lymphoblastic Leukemia in Children: Treatment Planning via Minimal Residual Disease Assessment Dtsch Arztebl Int 2012; 109(40): 652-8; DOI: 10.3238/arztebl.2012.0652